A multicenter RCT of 87 patients with juvenile idiopathic arthritis-associated uveitis found that discontinuing adalimumab led to significantly higher treatment failure rates compared to continued therapy, though all patients who experienced failure regained control after restarting treatment.
Key trial data and insights behind US Food and Drug Administration approvals of novel psychiatric drugs are shown, highlighting methods, demographics, and pivotal outcomes.
A large cohort study finds no link between montelukast use and neuropsychiatric adverse events in children, supporting its safety for asthma and allergic rhinitis management.
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
The U.S. Department of Health and Human Services has initiated a broad pause in public communications and travel, disrupting meetings, publications, and research funding approvals affecting human and animal health.
“You are instilling fear into folks who may defer care, who may go without care, whose children may not get the vaccines they need, who may not be able to get treatment for an ear infection or surgery."